Latest News from HNF

Stay up to date with our most recent news and updates on CMT and INs.

CMT1A Clinical Trial Update: Pharnext PREMIER trial of PXT3003

    CMT1A Clinical Trial Update: Pharnext PREMIER trial of PXT3003  The PREMIER Trial, which is being conducted in patients with mild-to-moderate CMT1A, is expected to enroll approximately 350 subjects ages 16-65 with a confirmed genetic diagnosis of CMT1A....

HNF Launches NEW Virtual CMT Fitness Platform with Ambassador Instructors

The Hereditary Neuropathy Foundation believes that activity plays an essential role in physical and mental well being, especially for people affected by debilitating diseases like Charcot-Marie-Tooth. The Movement is Medicine™ mission is to promote the safe adoption...

Mouse Models of Human CNTNAP1 Mutations: Strategies to Rescue and Restore Functions

MANZOOR A. BHAT, M.S., PH.D., DEPARTMENT OF CELLULAR AND INTEGRATIVE PHYSIOLOGY UT HEALTH SAN ANTONIO, TX Myelination of nerves has the sole purpose of allowing axons to propagate nerve impulses over long distances in a saltatory manner. Peripheral or central...

Act of Kindness: From Strangers to Instant Friends

On October 14, 2020, Winter School athletes in Wisconsin hit the Tuscobia Trail to raise much needed funding for HNF’s gene therapy program in support of Alana Kohler. This amazing school reached out to HNF after they saw a media piece on Alana Kohler who has GDAP1...
Act of Kindness: From Strangers to Instant Friends

Act of Kindness: From Strangers to Instant Friends

On October 14, 2020, Winter School athletes in Wisconsin hit the Tuscobia Trail to raise much needed funding for HNF’s gene therapy program in support of Alana Kohler. This amazing school reached out to HNF after they saw a media piece on Alana Kohler who has GDAP1...

read more

Archives